Temporal Dynamics of Pulmonary Fibrosis and Immune Dysregulation in a Collagen V-Driven Systemic Sclerosis Model
Authors:
- Vitória Elias ContiniVCVitória Elias Contini
- Zelita Aparecida J. QueirozZQZelita Aparecida J. Queiroz
- Sérgio CatanoziSCSérgio Catanozi
- Antonio dos Santos FilhoAFAntonio dos Santos Filho
- Lizandre Keren Ramos da SilveiraLSLizandre Keren Ramos da Silveira
- Aritania Sousa SantosASAritania Sousa Santos
- Sandra de Morais FernezlianSFSandra de Morais Fernezlian
- Denise FredianiDFDenise Frediani
- Thays de Matos LoboTLThays de Matos Lobo
- Jaíne Alves AlmeidaJAJaíne Alves Almeida
- Camila Machado BaldaviraCBCamila Machado Baldavira
- Ana Paula Pereira VelosaAVAna Paula Pereira Velosa
Open Access
- 24 December 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (1) , 197
Abstract
Systemic sclerosis (SSc) is a complex autoimmune disease characterized by progressive fibrosis and immune dysregulation, with lung involvement being a major cause of morbidity and mortality. Type V collagen (COLV), a cryptic self-antigen, has been implicated in the pathogenesis of fibrosis in both SSc and lung allograft dysfunction. To characterize the early histological, molecular, and immunological events associated with lung remodeling following immunization with COLV in a murine model (IMU-COLV), and to establish a temporal framework for fibrosis progression. Using a time-course design, lung tissue from IMU-COLV mice was analyzed at multiple intervals post-immunization. Histopathological assessment, immunohistochemistry, and gene expression analysis were performed to evaluate inflammation, endothelial activation, extracellular matrix remodeling, and collagen composition. We observed a progressive and spatially organized pattern of lung remodeling, beginning with peribronchovascular immune infiltration and culminating in airway-centered fibrosis. These changes were accompanied by dynamic endothelial activation, increased expression of profibrotic markers, and alterations in collagen architecture particularly involving COLV. The remodeling pattern closely mirrors histological features observed in early SSc-associated interstitial lung disease and other fibrotic conditions, such as idiopathic pulmonary fibrosis and chronic lung allograft dysfunsion. The IMU-COLV model recapitulates key early features of SSc-related lung fibrosis, highlighting COLV’s potential role as a driver of immune-mediated tissue remodeling. These findings provide a valuable platform for investigating the mechanisms underlying fibrogenesis and for testing targeted interventions in the early phases of pulmonary fibrosis.Keywords
Funding Information
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (001)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2018/00415-0)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2018/20403-6)
- Sociedade Brasileira de Reumatologia, Brazil (2023-16)
This publication has 53 references indexed in Scilit:
- Systemic sclerosisThe Lancet, 2022
- Recent advances in mouse models for systemic sclerosisAutoimmunity Reviews, 2018
- Idiopathic pulmonary fibrosisThe Lancet, 2017
- Type V Collagen in Health, Disease, and FibrosisThe Anatomical Record, 2016
- Abnormal collagen V deposition in dermis correlates with skin thickening and disease activity in systemic sclerosisAutoimmunity Reviews, 2012
- Toll-like receptors and macrophage activation in atherosclerosisClinica Chimica Acta, 2012
- Collagen type V modulates fibroblast behavior dependent on substrate stiffnessBiochemical and Biophysical Research Communications, 2009
- Collagen fibrillogenesis: fibronectin, integrins, and minor collagens as organizers and nucleatorsCurrent Opinion in Cell Biology, 2008
- Scleroderma-like remodeling induced by type V collagenArchives of Dermatological Research, 2006
- Regulated nucleosome mobility and the histone codeNature Structural & Molecular Biology, 2004